Allogene Therapeutics Inc
NASDAQ:ALLO

Watchlist Manager
Allogene Therapeutics Inc Logo
Allogene Therapeutics Inc
NASDAQ:ALLO
Watchlist
Price: 2.77 USD -7.97% Market Closed
Updated: May 18, 2024

Allogene Therapeutics Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Allogene Therapeutics Inc
Pre-Tax Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Allogene Therapeutics Inc
NASDAQ:ALLO
Pre-Tax Income
-$531.6m
CAGR 3-Years
-32%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Pre-Tax Income
$7.5B
CAGR 3-Years
22%
CAGR 5-Years
9%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Pre-Tax Income
$1.1B
CAGR 3-Years
-18%
CAGR 5-Years
-33%
CAGR 10-Years
-16%
Amgen Inc
NASDAQ:AMGN
Pre-Tax Income
$4.3B
CAGR 3-Years
-18%
CAGR 5-Years
-14%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Pre-Tax Income
$4.8B
CAGR 3-Years
13%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Pre-Tax Income
$4B
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
18%

See Also

What is Allogene Therapeutics Inc's Pre-Tax Income?
Pre-Tax Income
-531.6m USD

Based on the financial report for Mar 31, 2024, Allogene Therapeutics Inc's Pre-Tax Income amounts to -531.6m USD.

What is Allogene Therapeutics Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-17%

Over the last year, the Pre-Tax Income growth was -51%. The average annual Pre-Tax Income growth rates for Allogene Therapeutics Inc have been -32% over the past three years , -17% over the past five years .